4basebio (4BB) Stock Chart & Stock Price History GBX 940 -49.00 (-4.95%) As of 08/4/2025 06:11 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock 4basebio Stock Price Performance The 4basebio (4BB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 34.27%, with a year-to-date return of -20.07%. In the past month, the stock has decreased 2.84%, reflecting recent market activity. As of the latest close, 4basebio traded at GBX 940 with a market cap of £120.41 million and volume of 240 shares. Receive 4BB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.11%1 Month Performance-2.84%3 Month Performance-16.25%Year-To-Date Performance-20.07%1 Year Performance-34.27% 4BB Stock Chart for Tuesday, August, 5, 2025 4BB Chart by TradingView 4basebio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025GBX 989GBX 940-4.95%GBX 989GBX 940240 shs£120.41 million08/01/2025GBX 941GBX 989+5.10%GBX 990GBX 970448 shs£126.69 million07/31/2025GBX 943GBX 941-0.21%GBX 989GBX 9201,694 shs£120.54 million07/30/2025GBX 991GBX 943-4.84%GBX 970GBX 9431,005 shs£120.80 million07/29/2025GBX 991GBX 991GBX 991GBX 97019 shs£126.95 million07/28/2025GBX 941GBX 991+5.31%GBX 991GBX 97019 shs£126.95 million07/25/2025GBX 991GBX 941-5.05%GBX 965GBX 9412,400 shs£120.54 million07/24/2025GBX 979GBX 991+1.23%GBX 1,020GBX 940557 shs£126.95 million07/23/2025GBX 950GBX 979+3.05%GBX 979GBX 965408 shs£125.41 million07/22/2025GBX 950GBX 950GBX 980GBX 9405,174 shs£121.70 million Get the Latest News and Ratings for 4BB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025GBX 1,000GBX 950-5.00%GBX 980GBX 9405,174 shs£121.70 million07/18/2025GBX 995.50GBX 1,000+0.45%GBX 1,000GBX 9702,510 shs£128.10 million07/17/2025GBX 1,000GBX 995.50-0.45%GBX 1,000GBX 9734,339 shs£127.52 million07/16/2025GBX 1,028GBX 1,000-2.72%GBX 1,110GBX 9807,650 shs£128.10 million07/15/2025GBX 977.60GBX 1,028+5.16%GBX 1,028GBX 1,0004 shs£131.69 million07/14/2025GBX 1,005GBX 977.60-2.73%GBX 1,000GBX 96096 shs£125.23 million07/11/2025GBX 1,005GBX 1,005GBX 1,039.20GBX 1,000416 shs£128.74 million07/10/2025GBX 1,005GBX 1,005GBX 1,028GBX 1,000268 shs£128.74 million07/09/2025GBX 1,005GBX 1,005GBX 1,005GBX 1,0009,777 shs£128.74 million07/08/2025GBX 971GBX 1,005+3.50%GBX 1,005GBX 94079 shs£128.74 million07/07/2025GBX 985GBX 971-1.42%GBX 1,010GBX 9711,004 shs£124.39 million07/04/2025GBX 967.50GBX 985+1.81%GBX 1,010GBX 967.501,301 shs£126.18 million Related Companies PureTech Health Stock Chart Faron Pharmaceuticals Oy Stock Chart Avacta Group Stock Chart Bioventix Stock Chart Scancell Stock Chart Ondine Biomedical Stock Chart hVIVO Stock Chart Futura Medical Stock Chart SkinBioTherapeutics Stock Chart Tissue Regenix Group Stock Chart Receive 4BB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. This page (LON:4BB) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
